Bausch Health
BHC
#4619
Rank
โ‚น237.58 B
Marketcap
โ‚น635.28
Share price
-1.05%
Change (1 day)
-0.66%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2026 (TTM): -โ‚น307.11

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is -โ‚น309.10. In 2025 the company made an earnings per share (EPS) of โ‚น40.07 an increase over its 2024 EPS that were of -โ‚น11.45.

EPS history for Bausch Health from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น307.11-866.46%
2025โ‚น40.07-450%
2024-โ‚น11.45-92.59%
2023-โ‚น154.55160.89%
2022-โ‚น59.24-76.64%
2021-โ‚น253.5868.45%
2020-โ‚น150.53-68.91%
2019-โ‚น484.16-57.11%
2018-โ‚น1,129-272.22%
2017โ‚น655.52-199.29%
2016-โ‚น660.18798.7%
2015-โ‚น73.46-128.31%
2014โ‚น259.49-204.62%
2013-โ‚น248.05602.7%
2012-โ‚น35.30

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
-โ‚น25.76-91.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-โ‚น90.63-70.68%๐Ÿ‡บ๐Ÿ‡ธ USA